Aarey Drugs & Pharmaceuticals Ltd Financials

Aarey Drugs & Pharmaceuticals Ltd Financial Statement

Aarey Drugs & Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	105.16	128.49	215.49
Operating Expense	101.42	125.73	211.79
Net Profit	1.60	1.24	2.15
Net Profit Margin	1.52	0.97	1.00
Earning Per Share	0.57	0.44	0.77
EBIDTA	4	2.77	4.36
Effective Tax Rate	10.70	3.64	17.84

Particulars	Sep 2024
Revenue	105.16
Operating Expense	101.42
Net Profit	1.60
Net Profit Margin	1.52
Earning Per Share	0.57
EBIDTA	4.00
Effective Tax Rate	10.70

Aarey Drugs & Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	395.62	418.96	492.76
Operating Expenses Annual	391.17	411.24	481.37
Operating Profit Annual	11.42	10.45	14.06
Interest Annual	4.38	2.87	2.04
Depreciation	1.70	1.57	1.99
Net Profit Annual	4.68	3.77	6.55
Tax Annual	0.66	2.24	3.48

Particulars	Mar 2024
Total Revenue Annual	395.62
Operating Expenses Annual	391.17
Operating Profit Annual	11.42
Interest Annual	4.38
Depreciation	1.70
Net Profit Annual	4.68
Tax Annual	0.66

Aarey Drugs & Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.71	0.19	0.65
Cash Flow from Operations	-2.99	-1.28	0.50
Cash Flow from Investing	-1.70	0.44	-3.21
Cash Flow from Financing	5.58	1.35	2.25
Cash Flow at the End	1.59	0.71	0.19

Particulars	Mar 2024
Cash Flow at the Beginning	0.71
Cash Flow from Operations	-2.99
Cash Flow from Investing	-1.70
Cash Flow from Financing	5.58
Cash Flow at the End	1.59

Aarey Drugs & Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	2.89	2.49	2.86
PBIT Margin (%)	2.46	2.12	2.45
PBT Margin (%)	1.90	1.38	1.25
Net PROFIT Margin (%)	1.18	0.90	1.33
Return On Networth / Equity (%)	3.74	3.26	6.16
Return On Networth /Employed (%)	6.09	6.28	9.79
Return On Assets (%)	2.93	2.66	5.32
Total Debt / Equity (X)	0.28	0.22	0.15
Asset Turnover Ratio (%)	2.48	2.96	4

Particulars	Mar 2024
PBDIT Margin (%)	2.89
PBIT Margin (%)	2.46
PBT Margin (%)	1.90
Net PROFIT Margin (%)	1.18
Return On Networth / Equity (%)	3.74
Return On Networth /Employed (%)	6.09
Return On Assets (%)	2.93
Total Debt / Equity (X)	0.28
Asset Turnover Ratio (%)	2.48

Aarey Drugs & Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	12.96	13.94	14.47
Total Current Assets Annual	282.59	270.61	218.82
Non Current Assets Annual	20.71	20.72	26.35
Total Shareholders Funds Annual	132.77	117.41	113.64
Total Assets Annual	303.29	291.32	245.17

Particulars	Mar 2024
Fixed Assets Annual	12.96
Total Current Assets Annual	282.59
Non Current Assets Annual	20.71
Total Shareholders Funds Annual	132.77
Total Assets Annual	303.29

Aarey Drugs & Pharmaceuticals Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Aarey Drugs & Pharmaceuticals Ltd has a market capitalization of 124.90 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Aarey Drugs & Pharmaceuticals Ltd is debt-free with a debt-to-equity ratio of 0.24.

In FY 2023 , Aarey Drugs & Pharmaceuticals Ltd recorded a total revenue of approximately 395.62 Cr marking a significant milestone in the company's financial performance.

Aarey Drugs & Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and -0.1% annually, respectively..

Aarey Drugs & Pharmaceuticals Ltd's current PE ratio is 26.69.

Aarey Drugs & Pharmaceuticals Ltd's ROCE averaged 6.2% from the FY ending March 2022 to 2024, with a median of 4.9%. It peaked at 9.4% in March 2022, reflecting strong capital efficiency over the period..

Aarey Drugs & Pharmaceuticals Ltd's latest EBIT is Rs. 7.04 Cr, surpassing the average EBIT of Rs. 8.89 Cr over the 5 years..